Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Aevex Corp. (AVEX)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
$9.26-10.79%
Close 2026-11-05 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.67 → 0.69 EPS · FY ending Dec 31, 2027 · 6 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 6; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AVEX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Effective management of capital and funding | A supporting condition in Aevex Corp.'s published investment case. The stated target is maintain positive capital management. | Intact | fails to secure necessary funding or manage capital effectively | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
AVEX is a smaller-cap growth and expansion story, with a cyclical industrial backdrop. Recent execution is encouraging, but the long-term thesis remains insufficiently established because the available history is limited.
The evidence does not provide a valuation level or specific market expectations, so whether AVEX is cheap, fair, or expensive versus peers cannot be assessed. No fragility signals fired, but that does not establish what investors already assume.
In the near term, recent results show strong revenue growth and a shift to positive operating and net income, while the BlackSea acquisition expands the business. Management appears on track with growth and acquisition priorities, but capital allocation is mixed, and a recent earnings beat is only one data point. The industrial-sector headwind and weakening jobs trend could weigh on this cyclical business.
Over the next one to three years, the thesis depends on AVEX sustaining growth and improving profitability while integrating its acquisition. Sector bellwethers’ earnings and guidance are important signals: continued strength could support the industrial backdrop, while weaker results could remove that support. Further weakening in jobs could also increase recession concerns for cyclical companies.
AVEX has encouraging recent operating progress, but limited history, mixed capital allocation evidence, and a challenging sector backdrop leave the one-to-three-year thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit margins improved, reaching $15.37M in operating income. |
| Improving |
| falls below 10% operating margin next fiscal year |
Operating margin: 7.62% FY2026-Q2; GAAP. Published target: >=10% operating margin. Target period is not explicitly aligned with this observation. Aug 12, 20267.617287 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “BlackSea’s capabilities will be combined with AEVEX’s substantial portfolio of mission-proven Group I-V UAS, long-range precision strike systems, contested logistics capabilities, and ISR platforms, with more than 10,000 systems delivered and committed through 2026, supported by 114% year-over-year production volume growth in Q2 and strong supply-chain throughput improvements.” “BlackSea’s Baltimore manufacturing complex, featuring deepwater access, two 30-ton bridge cranes, advanced robotic welding, and ~40 USVs/month production capacity, joins AEVEX’s existing scaled domestic production network.” Delivery assessment Nov 5, 2026 |
Revenue growth through acquisitions and contracts | Aevex is growing through strategic acquisitions. | Intact | falls below 15% YoY growth next fiscal year | Revenue growth: 99.53% FY2026-Q2; GAAP. Published target: >=15% YoY. Target period is not explicitly aligned with this observation. Aug 12, 202699.528349 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “Press Release For Immediate Release Exhibit 99.1 AEVEX Completes Acquisition of BlackSea Technologies, Creating One of the Defense Industry’s Most Capable Multi-Domain Autonomous Systems Providers Closing advances AEVEX’s strategy by combining battle-proven air, surface, and subsea unmanned systems with scaled U.S. manufacturing, deep customer reach, and CompassX-enabled autonomy.” ““With demand for autonomous systems accelerating globally, customers are prioritizing providers who can deliver field-proven capability at scale,” said Roger Wells, Chief Executive Officer of AEVEX.” Delivery assessment Nov 5, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.61 → $0.69 · observed estimates
$0.74B → $0.86B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $0.61 | $743,799,040 | 4 / 6 |
| 2026-08-28 | $0.61 | $743,799,040 | 4 / 6 |
| 2026-08-29 | $0.62 | $767,389,714 | 4 / 6 |
| 2026-08-30 | $0.66 | $793,639,714 | 4 / 6 |
| 2026-08-31 | $0.66 | $793,639,714 | 4 / 5 |
| 2026-09-01 | $0.66 | $793,587,350 | 4 / 5 |
| 2026-09-02 | $0.66 | $793,587,350 | 4 / 5 |
| 2026-09-03 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-04 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-05 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-06 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-07 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-08 | $0.67 | $783,744,311 | 4 / 6 |
| 2026-09-09 | $0.68 | $802,641,833 | 4 / 6 |
| 2026-09-10 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-11 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-12 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-13 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-14 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-15 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-16 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-17 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-18 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-19 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-20 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-21 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-22 | $0.68 | $802,641,833 | 2 / 2 |
| 2026-09-23 | $0.67 | $811,397,650 | 2 / 2 |
| 2026-09-24 | $0.67 | $811,397,650 | 2 / 2 |
| 2026-09-25 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-09-26 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-09-27 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-09-28 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-09-29 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-09-30 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-01 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-02 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-03 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-04 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-05 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-06 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-07 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-08 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-09 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-10 | $0.67 | $811,397,650 | 2 / 3 |
| 2026-10-11 | $0.67 | $825,116,350 | 3 / 3 |
| 2026-10-12 | $0.67 | $825,116,350 | 3 / 3 |
| 2026-10-13 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-14 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-15 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-16 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-17 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-18 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-19 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-20 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-21 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-22 | $0.69 | $857,296,350 | 3 / 5 |
| 2026-10-23 | $0.69 | $861,525,038 | 4 / 6 |
| 2026-10-24 | $0.69 | $861,525,038 | 4 / 6 |
| 2026-10-25 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-26 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-27 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-28 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-29 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-30 | $0.69 | $861,525,038 | 6 / 7 |
| 2026-10-31 | $0.69 | $861,527,065 | 6 / 7 |
| 2026-11-01 | $0.69 | $861,527,065 | 6 / 7 |
| 2026-11-02 | $0.69 | $861,527,065 | 6 / 7 |
| 2026-11-03 | $0.69 | $861,527,065 | 6 / 7 |
| 2026-11-04 | $0.69 | $861,527,065 | 6 / 7 |
| 2026-11-05 | $0.69 | $861,527,065 | 6 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 10 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 3 recorded
0 raises · 2 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.